DOI:
10.1055/s-00030576
Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics
LinksClose Window
References
Minion LE, Bai J, Monk BJ. , et al.
A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer.
Gynecol Oncol 2015;
137 (03) 490-496 . Doi: 10.1016/j.ygyno.2015.02.027
We do not assume any responsibility for the contents of the web pages of other providers.